[Form 4] CeriBell, Inc. Insider Trading Activity
Ceribell, Inc. (CBLL) director and President & CEO Jane (Xingjuan) Chao reported a sale of 2,887 shares of common stock on 08/25/2025 at a price of $11.58 per share. After the sale, the filing shows Ms. Chao directly beneficially owns 773,135 shares. The report also discloses an indirect interest of 369,088 shares held by the ACP 2021 Trust, for which she is a co-trustee and from which she disclaims beneficial ownership except to the extent of her pecuniary interest.
The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing records a routine disposition of shares by an insider who holds substantial direct and indirect positions, and it includes the required explanatory note about the trustee relationship and disclaimer of beneficial ownership.
- Transparent disclosure of insider transaction with transaction date, price, and post-transaction direct holdings
- Clear explanation of indirect holdings via the ACP 2021 Trust and a disclaimer of beneficial ownership, which aids investor understanding
- No indication on the form that the sale was made under a pre-arranged 10b5-1 trading plan (box not checked), leaving the motive unspecified
Insights
TL;DR: Insider sale by the CEO/director is routine disclosure; co-trustee status explains indirect holdings and a disclaimer is standard.
The reported sale of 2,887 shares at $11.58 by the reporting person—who serves as both President & CEO and a director—appears to be a routine disposition rather than a structural change in control. The filing properly identifies both direct and indirect holdings and includes the co-trustee explanatory language, which clarifies the scope of claimed beneficial ownership. From a governance perspective, accurate Form 4 reporting preserves transparency; the presence of sizable direct and trust-held positions underscores alignment with shareholders but also concentrates insider exposure.
TL;DR: Small insider sale relative to total holdings; transaction itself is unlikely to be market-moving.
The disposition of 2,887 shares at $11.58 is modest compared with the reported direct holding of 773,135 shares and the 369,088 shares associated with the ACP 2021 Trust. The Form 4 discloses transaction details clearly, including the reporting person’s dual roles and trustee relationship. There is no additional transactional context such as a 10b5-1 plan indicated on the form, and no derivative transactions are reported. Based solely on the disclosed numbers, the sale is immaterial to company capitalization and likely reflects a personal liquidity event rather than corporate action.